EP Patent

EP0126580A2 — Vesicle formulations for the controlled release of therapeutic agents

Assigned to Nexstar Pharmaceuticals Inc · Expires 1984-11-28 · 41y expired

What this patent protects

Vesicle compositions provide controlled sustained release of an encapsulated therapeutic agent after parenteral administration, depending upon the difference in osmolarity between the suspending solution and the solution within the vesicles. By adjusting the concentration of the …

USPTO Abstract

Vesicle compositions provide controlled sustained release of an encapsulated therapeutic agent after parenteral administration, depending upon the difference in osmolarity between the suspending solution and the solution within the vesicles. By adjusting the concentration of the suspending sotution, the rate of release of the therapeutic agent after parenteral administration can be varied. The compositions can be effectively administered by intramuscular, subcutaneous injection or other means.

Drugs covered by this patent

Patent Metadata

Patent number
EP0126580A2
Jurisdiction
EP
Classification
—
Expires
1984-11-28
Drug substance claim
No
Drug product claim
No
Assignee
Nexstar Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.